Vassilev, L., Ranki, T., Joensuu, T., Jäger, E., Karbach, J., Wahle, C., . . . Pesonen, S. (2015). Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8(+) T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer. Oncoimmunology.
Chicago Style aipamenaVassilev, L., et al. "Repeated Intratumoral Administration of ONCOS-102 Leads to Systemic Antitumor CD8(+) T-cell Response and Robust Cellular and Transcriptional Immune Activation At Tumor Site in a Patient With Ovarian Cancer." Oncoimmunology 2015.
MLA aipamenaVassilev, L., et al. "Repeated Intratumoral Administration of ONCOS-102 Leads to Systemic Antitumor CD8(+) T-cell Response and Robust Cellular and Transcriptional Immune Activation At Tumor Site in a Patient With Ovarian Cancer." Oncoimmunology 2015.